Coral Laboratories has submitted a copy of statement of deviation or variation in public issue, rights issue, preferential issue etc. for the quarter ended March 31, 2016 under Regulation 32(1) of SEBI (Listing Obligations and Disclosure .Requirements) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.